Opmed.ai, a Boston, MA-based company specializing in healthcare optimization through AI technology, has secured $15 million in Series A funding.
Investors
The round was co-led by NFX and Grove Ventures, with participation from Secret Chord Ventures, the Impact investor Sir Ronald Cohen, and Unbox Ventures.
Founded in 2015, NFX Capital is a venture capital firm based in San Francisco, California. The firm invests in pre-seed and seed-stage startups.
Grove Ventures is a venture capital firm that prefers to invest in early-stage companies based in Israel. It was founded in 2017 and is based in Tel Aviv, Israel.
Opmed.ai Use of Funds
The company will use the funds to further expand its presence and impact in the healthcare optimization sector.
About Opmed.ai
Founded by Dr. Mor Brokman Meltzer, Avi Paz, and Prof. Baruch Barzel, Opmed.ai provides an AI optimization platform for healthcare, initially focusing on operating rooms. By leveraging advanced AI algorithms, Opmed.ai's platform can analyze vast amounts of data and generate alternative schedules tailored to specific healthcare industry requirements. The company has already gained traction with leading hospitals and healthcare centers in both countries and has established collaborations with prestigious institutions such as the Mayo Clinic.
Funding Details
Company: Opmed Inc.
Raised: $15.0M
Round: Series A
Funding Month: May 2024
Lead Investors: NFX, Grove Ventures
Additional Investors: Secret Chord Ventures, the Impact investor Sir Ronald Cohen, Unbox Ventures
Company Website: https://www.opmed.ai/
Software Category: Healthcare Optimization
Source: https://www.calcalistech.com/ctechnews/article/r1s5ss8mc